May 20 (Reuters) - Mineralys Therapeutics Inc MLYS.O:
MINERALYS ANNOUNCES LATE-BREAKING PRESENTATION OF PHASE 3 LAUNCH-HTN TRIAL AT 34TH EUROPEAN MEETING ON HYPERTENSION AND CARDIOVASCULAR PROTECTION
Source text: ID:nGNX4N2QPR
Further company coverage: MLYS.O
((Reuters.Briefs@thomsonreuters.com;))